MME and early-onset autosomal dominant Alzheimer disease: Intriguingly, membrane metallo-endopeptidase (MME), which is considered one of the important β-amyloid (Aβ)-degrading enzymes related to prevention of Alzheimer’s disease (AD) pathology [26], was identified with increased abundance in all H2O2 treatment groups.